NIH/National Institute of Allergy and Infectious Diseases

Diseases, Conditions, Syndromes

Exploring a key to hepatitis C entry into cells

In a new paper published in Nature, scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, describe the structure of a key protein on the surface of the ...

Diseases, Conditions, Syndromes

Investigational malaria vaccine gives strong, lasting protection

Two U.S. Phase 1 clinical trials of a novel candidate malaria vaccine have found that the regimen conferred unprecedentedly high levels of durable protection when volunteers were later exposed to disease-causing malaria parasites. ...

Diseases, Conditions, Syndromes

T cells recognize recent SARS-CoV-2 variants

When variants of SARS-CoV-2 (the virus that causes COVID-19) emerged in late 2020, concern arose that they might elude protective immune responses generated by prior infection or vaccination, potentially making re-infection ...

Diseases, Conditions, Syndromes

Scientists demonstrate how genetic variations cause eczema

New research supported by the National Institutes of Health delineates how two relatively common variations in a gene called KIF3A are responsible for an impaired skin barrier that allows increased water loss from the skin, ...

page 3 from 40